nodes	percent_of_prediction	percent_of_DWPC	metapath
Metaxalone—Rash—Lapatinib—breast cancer	0.00514	0.00514	CcSEcCtD
Metaxalone—Dermatitis—Lapatinib—breast cancer	0.00513	0.00513	CcSEcCtD
Metaxalone—Headache—Lapatinib—breast cancer	0.00511	0.00511	CcSEcCtD
Metaxalone—Dizziness—Fulvestrant—breast cancer	0.00496	0.00496	CcSEcCtD
Metaxalone—Jaundice—Thiotepa—breast cancer	0.00494	0.00494	CcSEcCtD
Metaxalone—Dizziness—Toremifene—breast cancer	0.00489	0.00489	CcSEcCtD
Metaxalone—Leukopenia—Chlorambucil—breast cancer	0.00488	0.00488	CcSEcCtD
Metaxalone—Nausea—Lapatinib—breast cancer	0.00484	0.00484	CcSEcCtD
Metaxalone—Hypersensitivity—Exemestane—breast cancer	0.0048	0.0048	CcSEcCtD
Metaxalone—Vomiting—Fulvestrant—breast cancer	0.00477	0.00477	CcSEcCtD
Metaxalone—Rash—Fulvestrant—breast cancer	0.00473	0.00473	CcSEcCtD
Metaxalone—Dermatitis—Fulvestrant—breast cancer	0.00472	0.00472	CcSEcCtD
Metaxalone—Vomiting—Toremifene—breast cancer	0.0047	0.0047	CcSEcCtD
Metaxalone—Headache—Fulvestrant—breast cancer	0.0047	0.0047	CcSEcCtD
Metaxalone—Rash—Toremifene—breast cancer	0.00466	0.00466	CcSEcCtD
Metaxalone—Dermatitis—Toremifene—breast cancer	0.00466	0.00466	CcSEcCtD
Metaxalone—Headache—Toremifene—breast cancer	0.00463	0.00463	CcSEcCtD
Metaxalone—Pruritus—Exemestane—breast cancer	0.00461	0.00461	CcSEcCtD
Metaxalone—Tension—Goserelin—breast cancer	0.00455	0.00455	CcSEcCtD
Metaxalone—Hypersensitivity—Ixabepilone—breast cancer	0.00453	0.00453	CcSEcCtD
Metaxalone—Nervousness—Goserelin—breast cancer	0.0045	0.0045	CcSEcCtD
Metaxalone—Leukopenia—Vinblastine—breast cancer	0.00447	0.00447	CcSEcCtD
Metaxalone—Nausea—Fulvestrant—breast cancer	0.00445	0.00445	CcSEcCtD
Metaxalone—Nausea—Toremifene—breast cancer	0.00439	0.00439	CcSEcCtD
Metaxalone—Drowsiness—Mitoxantrone—breast cancer	0.00438	0.00438	CcSEcCtD
Metaxalone—Pruritus—Ixabepilone—breast cancer	0.00435	0.00435	CcSEcCtD
Metaxalone—Leukopenia—Tamoxifen—breast cancer	0.00434	0.00434	CcSEcCtD
Metaxalone—Dizziness—Exemestane—breast cancer	0.00431	0.00431	CcSEcCtD
Metaxalone—Jaundice—Mitoxantrone—breast cancer	0.00427	0.00427	CcSEcCtD
Metaxalone—Jaundice—Irinotecan—breast cancer	0.00427	0.00427	CcSEcCtD
Metaxalone—Hypersensitivity—Anastrozole—breast cancer	0.00426	0.00426	CcSEcCtD
Metaxalone—Leukopenia—Melphalan—breast cancer	0.00425	0.00425	CcSEcCtD
Metaxalone—Haemolytic anaemia—Capecitabine—breast cancer	0.00421	0.00421	CcSEcCtD
Metaxalone—Leukopenia—Goserelin—breast cancer	0.00415	0.00415	CcSEcCtD
Metaxalone—Vomiting—Exemestane—breast cancer	0.00414	0.00414	CcSEcCtD
Metaxalone—Rash—Exemestane—breast cancer	0.0041	0.0041	CcSEcCtD
Metaxalone—Dermatitis—Exemestane—breast cancer	0.0041	0.0041	CcSEcCtD
Metaxalone—Pruritus—Anastrozole—breast cancer	0.00409	0.00409	CcSEcCtD
Metaxalone—Pruritus—Letrozole—breast cancer	0.00409	0.00409	CcSEcCtD
Metaxalone—Headache—Exemestane—breast cancer	0.00408	0.00408	CcSEcCtD
Metaxalone—Dizziness—Ixabepilone—breast cancer	0.00406	0.00406	CcSEcCtD
Metaxalone—Hypersensitivity—Idarubicin—breast cancer	0.00404	0.00404	CcSEcCtD
Metaxalone—Vomiting—Ixabepilone—breast cancer	0.00391	0.00391	CcSEcCtD
Metaxalone—Tension—Thiotepa—breast cancer	0.00389	0.00389	CcSEcCtD
Metaxalone—Anaphylactic shock—Melphalan—breast cancer	0.00388	0.00388	CcSEcCtD
Metaxalone—Rash—Ixabepilone—breast cancer	0.00387	0.00387	CcSEcCtD
Metaxalone—Dermatitis—Ixabepilone—breast cancer	0.00387	0.00387	CcSEcCtD
Metaxalone—Nausea—Exemestane—breast cancer	0.00387	0.00387	CcSEcCtD
Metaxalone—Nervousness—Thiotepa—breast cancer	0.00385	0.00385	CcSEcCtD
Metaxalone—Headache—Ixabepilone—breast cancer	0.00385	0.00385	CcSEcCtD
Metaxalone—Dizziness—Anastrozole—breast cancer	0.00383	0.00383	CcSEcCtD
Metaxalone—Dizziness—Letrozole—breast cancer	0.00383	0.00383	CcSEcCtD
Metaxalone—Anaphylactic shock—Goserelin—breast cancer	0.00378	0.00378	CcSEcCtD
Metaxalone—Leukopenia—Vinorelbine—breast cancer	0.00371	0.00371	CcSEcCtD
Metaxalone—Vomiting—Anastrozole—breast cancer	0.00368	0.00368	CcSEcCtD
Metaxalone—Vomiting—Letrozole—breast cancer	0.00368	0.00368	CcSEcCtD
Metaxalone—Nausea—Ixabepilone—breast cancer	0.00365	0.00365	CcSEcCtD
Metaxalone—Rash—Letrozole—breast cancer	0.00365	0.00365	CcSEcCtD
Metaxalone—Rash—Anastrozole—breast cancer	0.00365	0.00365	CcSEcCtD
Metaxalone—Dermatitis—Letrozole—breast cancer	0.00364	0.00364	CcSEcCtD
Metaxalone—Dermatitis—Anastrozole—breast cancer	0.00364	0.00364	CcSEcCtD
Metaxalone—Dizziness—Raloxifene—breast cancer	0.00363	0.00363	CcSEcCtD
Metaxalone—Irritability—Capecitabine—breast cancer	0.00363	0.00363	CcSEcCtD
Metaxalone—Headache—Anastrozole—breast cancer	0.00362	0.00362	CcSEcCtD
Metaxalone—Headache—Letrozole—breast cancer	0.00362	0.00362	CcSEcCtD
Metaxalone—Leukopenia—Thiotepa—breast cancer	0.00355	0.00355	CcSEcCtD
Metaxalone—Vomiting—Raloxifene—breast cancer	0.00349	0.00349	CcSEcCtD
Metaxalone—Vomiting—Idarubicin—breast cancer	0.00349	0.00349	CcSEcCtD
Metaxalone—Rash—Idarubicin—breast cancer	0.00346	0.00346	CcSEcCtD
Metaxalone—Rash—Raloxifene—breast cancer	0.00346	0.00346	CcSEcCtD
Metaxalone—Dermatitis—Idarubicin—breast cancer	0.00346	0.00346	CcSEcCtD
Metaxalone—Dermatitis—Raloxifene—breast cancer	0.00346	0.00346	CcSEcCtD
Metaxalone—Headache—Raloxifene—breast cancer	0.00344	0.00344	CcSEcCtD
Metaxalone—Headache—Idarubicin—breast cancer	0.00344	0.00344	CcSEcCtD
Metaxalone—Nausea—Letrozole—breast cancer	0.00344	0.00344	CcSEcCtD
Metaxalone—Nausea—Anastrozole—breast cancer	0.00344	0.00344	CcSEcCtD
Metaxalone—Anaphylactic shock—Vinorelbine—breast cancer	0.00339	0.00339	CcSEcCtD
Metaxalone—Somnolence—Goserelin—breast cancer	0.00336	0.00336	CcSEcCtD
Metaxalone—Hypersensitivity—Chlorambucil—breast cancer	0.00328	0.00328	CcSEcCtD
Metaxalone—Nausea—Raloxifene—breast cancer	0.00326	0.00326	CcSEcCtD
Metaxalone—Nausea—Idarubicin—breast cancer	0.00326	0.00326	CcSEcCtD
Metaxalone—Abdominal discomfort—Capecitabine—breast cancer	0.00315	0.00315	CcSEcCtD
Metaxalone—Pruritus—Chlorambucil—breast cancer	0.00315	0.00315	CcSEcCtD
Metaxalone—Leukopenia—Mitoxantrone—breast cancer	0.00306	0.00306	CcSEcCtD
Metaxalone—Leukopenia—Irinotecan—breast cancer	0.00306	0.00306	CcSEcCtD
Metaxalone—Hypersensitivity—Vinblastine—breast cancer	0.003	0.003	CcSEcCtD
Metaxalone—Leukopenia—Gemcitabine—breast cancer	0.00298	0.00298	CcSEcCtD
Metaxalone—Jaundice—Docetaxel—breast cancer	0.00295	0.00295	CcSEcCtD
Metaxalone—Leukopenia—Fluorouracil—breast cancer	0.00293	0.00293	CcSEcCtD
Metaxalone—Anaphylactoid reaction—Methotrexate—breast cancer	0.00292	0.00292	CcSEcCtD
Metaxalone—Hypersensitivity—Tamoxifen—breast cancer	0.00292	0.00292	CcSEcCtD
Metaxalone—Somnolence—Thiotepa—breast cancer	0.00287	0.00287	CcSEcCtD
Metaxalone—Jaundice—Capecitabine—breast cancer	0.00286	0.00286	CcSEcCtD
Metaxalone—Hypersensitivity—Melphalan—breast cancer	0.00286	0.00286	CcSEcCtD
Metaxalone—Vomiting—Chlorambucil—breast cancer	0.00283	0.00283	CcSEcCtD
Metaxalone—Pruritus—Tamoxifen—breast cancer	0.0028	0.0028	CcSEcCtD
Metaxalone—Anaphylactic shock—Mitoxantrone—breast cancer	0.00279	0.00279	CcSEcCtD
Metaxalone—Anaphylactic shock—Irinotecan—breast cancer	0.00279	0.00279	CcSEcCtD
Metaxalone—Hypersensitivity—Goserelin—breast cancer	0.00279	0.00279	CcSEcCtD
Metaxalone—Pruritus—Melphalan—breast cancer	0.00274	0.00274	CcSEcCtD
Metaxalone—Tension—Paclitaxel—breast cancer	0.00274	0.00274	CcSEcCtD
Metaxalone—Anaphylactoid reaction—Epirubicin—breast cancer	0.00274	0.00274	CcSEcCtD
Metaxalone—Anaphylactic shock—Gemcitabine—breast cancer	0.00272	0.00272	CcSEcCtD
Metaxalone—Nervousness—Paclitaxel—breast cancer	0.00271	0.00271	CcSEcCtD
Metaxalone—Irritability—Methotrexate—breast cancer	0.0027	0.0027	CcSEcCtD
Metaxalone—Dizziness—Vinblastine—breast cancer	0.00269	0.00269	CcSEcCtD
Metaxalone—Pruritus—Goserelin—breast cancer	0.00267	0.00267	CcSEcCtD
Metaxalone—Anaphylactic shock—Fluorouracil—breast cancer	0.00267	0.00267	CcSEcCtD
Metaxalone—Nausea—Chlorambucil—breast cancer	0.00264	0.00264	CcSEcCtD
Metaxalone—Dizziness—Tamoxifen—breast cancer	0.00262	0.00262	CcSEcCtD
Metaxalone—Vomiting—Vinblastine—breast cancer	0.00259	0.00259	CcSEcCtD
Metaxalone—Headache—Vinblastine—breast cancer	0.00255	0.00255	CcSEcCtD
Metaxalone—Anaphylactoid reaction—Doxorubicin—breast cancer	0.00253	0.00253	CcSEcCtD
Metaxalone—Vomiting—Tamoxifen—breast cancer	0.00252	0.00252	CcSEcCtD
Metaxalone—Dizziness—Goserelin—breast cancer	0.0025	0.0025	CcSEcCtD
Metaxalone—Leukopenia—Paclitaxel—breast cancer	0.0025	0.0025	CcSEcCtD
Metaxalone—Rash—Tamoxifen—breast cancer	0.0025	0.0025	CcSEcCtD
Metaxalone—Hypersensitivity—Vinorelbine—breast cancer	0.00249	0.00249	CcSEcCtD
Metaxalone—Dermatitis—Tamoxifen—breast cancer	0.00249	0.00249	CcSEcCtD
Metaxalone—Somnolence—Mitoxantrone—breast cancer	0.00248	0.00248	CcSEcCtD
Metaxalone—Somnolence—Irinotecan—breast cancer	0.00248	0.00248	CcSEcCtD
Metaxalone—Headache—Tamoxifen—breast cancer	0.00248	0.00248	CcSEcCtD
Metaxalone—Vomiting—Melphalan—breast cancer	0.00246	0.00246	CcSEcCtD
Metaxalone—Rash—Melphalan—breast cancer	0.00244	0.00244	CcSEcCtD
Metaxalone—Dermatitis—Melphalan—breast cancer	0.00244	0.00244	CcSEcCtD
Metaxalone—Nausea—Vinblastine—breast cancer	0.00242	0.00242	CcSEcCtD
Metaxalone—Somnolence—Gemcitabine—breast cancer	0.00242	0.00242	CcSEcCtD
Metaxalone—Vomiting—Goserelin—breast cancer	0.0024	0.0024	CcSEcCtD
Metaxalone—Pruritus—Vinorelbine—breast cancer	0.0024	0.0024	CcSEcCtD
Metaxalone—Rash—Goserelin—breast cancer	0.00238	0.00238	CcSEcCtD
Metaxalone—Hypersensitivity—Thiotepa—breast cancer	0.00238	0.00238	CcSEcCtD
Metaxalone—Dermatitis—Goserelin—breast cancer	0.00238	0.00238	CcSEcCtD
Metaxalone—Somnolence—Fluorouracil—breast cancer	0.00238	0.00238	CcSEcCtD
Metaxalone—Headache—Goserelin—breast cancer	0.00237	0.00237	CcSEcCtD
Metaxalone—Nausea—Tamoxifen—breast cancer	0.00235	0.00235	CcSEcCtD
Metaxalone—Abdominal discomfort—Methotrexate—breast cancer	0.00235	0.00235	CcSEcCtD
Metaxalone—Nausea—Melphalan—breast cancer	0.0023	0.0023	CcSEcCtD
Metaxalone—Pruritus—Thiotepa—breast cancer	0.00229	0.00229	CcSEcCtD
Metaxalone—Anaphylactic shock—Paclitaxel—breast cancer	0.00228	0.00228	CcSEcCtD
Metaxalone—Nausea—Goserelin—breast cancer	0.00225	0.00225	CcSEcCtD
Metaxalone—Dizziness—Vinorelbine—breast cancer	0.00224	0.00224	CcSEcCtD
Metaxalone—Drowsiness—Methotrexate—breast cancer	0.00218	0.00218	CcSEcCtD
Metaxalone—Vomiting—Vinorelbine—breast cancer	0.00215	0.00215	CcSEcCtD
Metaxalone—Dizziness—Thiotepa—breast cancer	0.00214	0.00214	CcSEcCtD
Metaxalone—Rash—Vinorelbine—breast cancer	0.00214	0.00214	CcSEcCtD
Metaxalone—Dermatitis—Vinorelbine—breast cancer	0.00213	0.00213	CcSEcCtD
Metaxalone—Headache—Vinorelbine—breast cancer	0.00212	0.00212	CcSEcCtD
Metaxalone—Leukopenia—Docetaxel—breast cancer	0.00212	0.00212	CcSEcCtD
Metaxalone—Hypersensitivity—Mitoxantrone—breast cancer	0.00206	0.00206	CcSEcCtD
Metaxalone—Hypersensitivity—Irinotecan—breast cancer	0.00206	0.00206	CcSEcCtD
Metaxalone—Vomiting—Thiotepa—breast cancer	0.00206	0.00206	CcSEcCtD
Metaxalone—Leukopenia—Capecitabine—breast cancer	0.00205	0.00205	CcSEcCtD
Metaxalone—Drowsiness—Epirubicin—breast cancer	0.00204	0.00204	CcSEcCtD
Metaxalone—Rash—Thiotepa—breast cancer	0.00204	0.00204	CcSEcCtD
Metaxalone—Dermatitis—Thiotepa—breast cancer	0.00204	0.00204	CcSEcCtD
Metaxalone—Headache—Thiotepa—breast cancer	0.00203	0.00203	CcSEcCtD
Metaxalone—Somnolence—Paclitaxel—breast cancer	0.00202	0.00202	CcSEcCtD
Metaxalone—Nausea—Vinorelbine—breast cancer	0.00201	0.00201	CcSEcCtD
Metaxalone—Jaundice—Epirubicin—breast cancer	0.00199	0.00199	CcSEcCtD
Metaxalone—Hypersensitivity—Fluorouracil—breast cancer	0.00197	0.00197	CcSEcCtD
Metaxalone—Anaphylactic shock—Docetaxel—breast cancer	0.00193	0.00193	CcSEcCtD
Metaxalone—Pruritus—Gemcitabine—breast cancer	0.00192	0.00192	CcSEcCtD
Metaxalone—Nausea—Thiotepa—breast cancer	0.00192	0.00192	CcSEcCtD
Metaxalone—Pruritus—Fluorouracil—breast cancer	0.00189	0.00189	CcSEcCtD
Metaxalone—Drowsiness—Doxorubicin—breast cancer	0.00189	0.00189	CcSEcCtD
Metaxalone—Dizziness—Irinotecan—breast cancer	0.00185	0.00185	CcSEcCtD
Metaxalone—Jaundice—Doxorubicin—breast cancer	0.00184	0.00184	CcSEcCtD
Metaxalone—Vomiting—Mitoxantrone—breast cancer	0.00178	0.00178	CcSEcCtD
Metaxalone—Vomiting—Irinotecan—breast cancer	0.00178	0.00178	CcSEcCtD
Metaxalone—Dizziness—Fluorouracil—breast cancer	0.00177	0.00177	CcSEcCtD
Metaxalone—Rash—Mitoxantrone—breast cancer	0.00176	0.00176	CcSEcCtD
Metaxalone—Rash—Irinotecan—breast cancer	0.00176	0.00176	CcSEcCtD
Metaxalone—Dermatitis—Irinotecan—breast cancer	0.00176	0.00176	CcSEcCtD
Metaxalone—Dermatitis—Mitoxantrone—breast cancer	0.00176	0.00176	CcSEcCtD
Metaxalone—Headache—Mitoxantrone—breast cancer	0.00175	0.00175	CcSEcCtD
Metaxalone—Headache—Irinotecan—breast cancer	0.00175	0.00175	CcSEcCtD
Metaxalone—Vomiting—Gemcitabine—breast cancer	0.00173	0.00173	CcSEcCtD
Metaxalone—Somnolence—Docetaxel—breast cancer	0.00172	0.00172	CcSEcCtD
Metaxalone—Rash—Gemcitabine—breast cancer	0.00172	0.00172	CcSEcCtD
Metaxalone—Dermatitis—Gemcitabine—breast cancer	0.00171	0.00171	CcSEcCtD
Metaxalone—Headache—Gemcitabine—breast cancer	0.0017	0.0017	CcSEcCtD
Metaxalone—Vomiting—Fluorouracil—breast cancer	0.0017	0.0017	CcSEcCtD
Metaxalone—Rash—Fluorouracil—breast cancer	0.00169	0.00169	CcSEcCtD
Metaxalone—Dermatitis—Fluorouracil—breast cancer	0.00168	0.00168	CcSEcCtD
Metaxalone—Hypersensitivity—Paclitaxel—breast cancer	0.00168	0.00168	CcSEcCtD
Metaxalone—Headache—Fluorouracil—breast cancer	0.00168	0.00168	CcSEcCtD
Metaxalone—Nausea—Mitoxantrone—breast cancer	0.00166	0.00166	CcSEcCtD
Metaxalone—Nausea—Irinotecan—breast cancer	0.00166	0.00166	CcSEcCtD
Metaxalone—Nausea—Gemcitabine—breast cancer	0.00162	0.00162	CcSEcCtD
Metaxalone—Pruritus—Paclitaxel—breast cancer	0.00161	0.00161	CcSEcCtD
Metaxalone—Nausea—Fluorouracil—breast cancer	0.00159	0.00159	CcSEcCtD
Metaxalone—Tension—Epirubicin—breast cancer	0.00157	0.00157	CcSEcCtD
Metaxalone—Nervousness—Epirubicin—breast cancer	0.00155	0.00155	CcSEcCtD
Metaxalone—Leukopenia—Methotrexate—breast cancer	0.00153	0.00153	CcSEcCtD
Metaxalone—Dizziness—Paclitaxel—breast cancer	0.00151	0.00151	CcSEcCtD
Metaxalone—Tension—Doxorubicin—breast cancer	0.00145	0.00145	CcSEcCtD
Metaxalone—Vomiting—Paclitaxel—breast cancer	0.00145	0.00145	CcSEcCtD
Metaxalone—Rash—Paclitaxel—breast cancer	0.00144	0.00144	CcSEcCtD
Metaxalone—Dermatitis—Paclitaxel—breast cancer	0.00143	0.00143	CcSEcCtD
Metaxalone—Nervousness—Doxorubicin—breast cancer	0.00143	0.00143	CcSEcCtD
Metaxalone—Leukopenia—Epirubicin—breast cancer	0.00143	0.00143	CcSEcCtD
Metaxalone—Headache—Paclitaxel—breast cancer	0.00143	0.00143	CcSEcCtD
Metaxalone—Hypersensitivity—Docetaxel—breast cancer	0.00142	0.00142	CcSEcCtD
Metaxalone—Anaphylactic shock—Methotrexate—breast cancer	0.00139	0.00139	CcSEcCtD
Metaxalone—Hypersensitivity—Capecitabine—breast cancer	0.00138	0.00138	CcSEcCtD
Metaxalone—Pruritus—Docetaxel—breast cancer	0.00137	0.00137	CcSEcCtD
Metaxalone—Nausea—Paclitaxel—breast cancer	0.00135	0.00135	CcSEcCtD
Metaxalone—Pruritus—Capecitabine—breast cancer	0.00132	0.00132	CcSEcCtD
Metaxalone—Leukopenia—Doxorubicin—breast cancer	0.00132	0.00132	CcSEcCtD
Metaxalone—Anaphylactic shock—Epirubicin—breast cancer	0.0013	0.0013	CcSEcCtD
Metaxalone—Dizziness—Docetaxel—breast cancer	0.00128	0.00128	CcSEcCtD
Metaxalone—Somnolence—Methotrexate—breast cancer	0.00124	0.00124	CcSEcCtD
Metaxalone—Dizziness—Capecitabine—breast cancer	0.00124	0.00124	CcSEcCtD
Metaxalone—Vomiting—Docetaxel—breast cancer	0.00123	0.00123	CcSEcCtD
Metaxalone—Rash—Docetaxel—breast cancer	0.00122	0.00122	CcSEcCtD
Metaxalone—Dermatitis—Docetaxel—breast cancer	0.00122	0.00122	CcSEcCtD
Metaxalone—Headache—Docetaxel—breast cancer	0.00121	0.00121	CcSEcCtD
Metaxalone—Anaphylactic shock—Doxorubicin—breast cancer	0.0012	0.0012	CcSEcCtD
Metaxalone—Vomiting—Capecitabine—breast cancer	0.00119	0.00119	CcSEcCtD
Metaxalone—Rash—Capecitabine—breast cancer	0.00118	0.00118	CcSEcCtD
Metaxalone—Dermatitis—Capecitabine—breast cancer	0.00118	0.00118	CcSEcCtD
Metaxalone—Headache—Capecitabine—breast cancer	0.00117	0.00117	CcSEcCtD
Metaxalone—Somnolence—Epirubicin—breast cancer	0.00116	0.00116	CcSEcCtD
Metaxalone—Nausea—Docetaxel—breast cancer	0.00115	0.00115	CcSEcCtD
Metaxalone—Nausea—Capecitabine—breast cancer	0.00111	0.00111	CcSEcCtD
Metaxalone—Somnolence—Doxorubicin—breast cancer	0.00107	0.00107	CcSEcCtD
Metaxalone—Hypersensitivity—Methotrexate—breast cancer	0.00103	0.00103	CcSEcCtD
Metaxalone—Pruritus—Methotrexate—breast cancer	0.000984	0.000984	CcSEcCtD
Metaxalone—Hypersensitivity—Epirubicin—breast cancer	0.000959	0.000959	CcSEcCtD
Metaxalone—Pruritus—Epirubicin—breast cancer	0.000921	0.000921	CcSEcCtD
Metaxalone—Dizziness—Methotrexate—breast cancer	0.00092	0.00092	CcSEcCtD
Metaxalone—Hypersensitivity—Doxorubicin—breast cancer	0.000888	0.000888	CcSEcCtD
Metaxalone—Vomiting—Methotrexate—breast cancer	0.000885	0.000885	CcSEcCtD
Metaxalone—Rash—Methotrexate—breast cancer	0.000877	0.000877	CcSEcCtD
Metaxalone—Dermatitis—Methotrexate—breast cancer	0.000877	0.000877	CcSEcCtD
Metaxalone—Headache—Methotrexate—breast cancer	0.000872	0.000872	CcSEcCtD
Metaxalone—Dizziness—Epirubicin—breast cancer	0.000861	0.000861	CcSEcCtD
Metaxalone—Pruritus—Doxorubicin—breast cancer	0.000852	0.000852	CcSEcCtD
Metaxalone—Vomiting—Epirubicin—breast cancer	0.000828	0.000828	CcSEcCtD
Metaxalone—Nausea—Methotrexate—breast cancer	0.000826	0.000826	CcSEcCtD
Metaxalone—Rash—Epirubicin—breast cancer	0.000821	0.000821	CcSEcCtD
Metaxalone—Dermatitis—Epirubicin—breast cancer	0.00082	0.00082	CcSEcCtD
Metaxalone—Headache—Epirubicin—breast cancer	0.000816	0.000816	CcSEcCtD
Metaxalone—Dizziness—Doxorubicin—breast cancer	0.000797	0.000797	CcSEcCtD
Metaxalone—Nausea—Epirubicin—breast cancer	0.000773	0.000773	CcSEcCtD
Metaxalone—Vomiting—Doxorubicin—breast cancer	0.000766	0.000766	CcSEcCtD
Metaxalone—Rash—Doxorubicin—breast cancer	0.00076	0.00076	CcSEcCtD
Metaxalone—Dermatitis—Doxorubicin—breast cancer	0.000759	0.000759	CcSEcCtD
Metaxalone—Headache—Doxorubicin—breast cancer	0.000755	0.000755	CcSEcCtD
Metaxalone—Nausea—Doxorubicin—breast cancer	0.000716	0.000716	CcSEcCtD
